Systemic lupus erythematosus (SLE) is an autoimmune disorder that affects approximately 322,000 people in the United States. The hallmark of this potentially fatal disorder is the production of autoantibodies, by autoreactive B-cells, against nuclear antigens. Currently, there is no cure for lupus and multiple B-cell targeted therapies have not been successful in clinical trials.
The aim of this proposal is to study mechanisms of B-cell tolerance in the triple congenic (TC), Fas-sufficient, murine lupus background by means of the well characterized AM14 heavy chain transgenic mouse model. In this system, the AM14 rheumatoid factor (RF) binds exclusively to IgG2aa and not IgG2ab antibodies. Therefore, the AM14 system can be adapted to be in the presence or absence of the autoantigen. The first goal of the proposal is to characterize the activation of the RF AM14 B-cells in the TC background. Exogenous administration of autoantigen in young mice will be utilized to determine the role of the B-cell receptor, Toll-like receptors and non-specific factorsin the activation of the RF B-cells. The second goal will determine, through cell transfer experiments, whether the RF B-cells are anergized in the autoimmune and non-autoimmune backgrounds. In addition, the role of CD4 T-cells and TC-derived DCs in RF B-cell activation will be determined. Finally, the marginal zone and follicular distribution of the AM14 RF B-cells and its role in the breakdown of tolerance will be studied via histology and flow cytometry. A thorough understanding of B-cell tolerance and the breakdown that occurs in SLE will provide targets for future B-cell therapies.

Public Health Relevance

Currently, B-cell targeted therapies in lupus patients have failed or produced mixed results in clinical trials. Therefore, a comprehensive understanding of B-cell functions is required for the development of new B- cell targeted therapies for lupus.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Predoctoral Individual National Research Service Award (F31)
Project #
Application #
Study Section
Special Emphasis Panel (ZRG1-F07-E (20))
Program Officer
Adger-Johnson, Diane S
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Florida
Schools of Medicine
United States
Zip Code
Sang, Allison; Zheng, Ying Yi; Choi, Seung-Chul et al. (2015) Genetic and cellular dissection of the activation of AM14 rheumatoid factor B cells in a mouse model of lupus. J Leukoc Biol 98:209-21
Sang, Allison; Niu, Haitao; Cullen, Jaime et al. (2014) Activation of rheumatoid factor-specific B cells is antigen dependent and occurs preferentially outside of germinal centers in the lupus-prone NZM2410 mouse model. J Immunol 193:1609-21
Sang, Allison; Yin, Yiming; Zheng, Ying-Yi et al. (2012) Animal models of molecular pathology systemic lupus erythematosus. Prog Mol Biol Transl Sci 105:321-70
Potula, Hari-Hara S K; Xu, Zhiwei; Zeumer, Leilani et al. (2012) Cyclin-dependent kinase inhibitor Cdkn2c deficiency promotes B1a cell expansion and autoimmunity in a mouse model of lupus. J Immunol 189:2931-40
Zeumer, L; Sang, A; Niu, H et al. (2011) Murine lupus susceptibility locus Sle2 activates DNA-reactive B cells through two sub-loci with distinct phenotypes. Genes Immun 12:199-207
Perry, Daniel; Sang, Allison; Yin, Yiming et al. (2011) Murine models of systemic lupus erythematosus. J Biomed Biotechnol 2011:271694